[
  {
    "ts": null,
    "headline": "Boston Scientific (BSX) Stock Falls Amid Market Uptick: What Investors Need to Know",
    "summary": "The latest trading day saw Boston Scientific (BSX) settling at $91.75, representing a -1.02% change from its previous close.",
    "url": "https://finnhub.io/api/news?id=4a3463cf0942c4cb6c1b61014dd786c704105e2851cea4280d5437ba38b40932",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765494003,
      "headline": "Boston Scientific (BSX) Stock Falls Amid Market Uptick: What Investors Need to Know",
      "id": 137767058,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "The latest trading day saw Boston Scientific (BSX) settling at $91.75, representing a -1.02% change from its previous close.",
      "url": "https://finnhub.io/api/news?id=4a3463cf0942c4cb6c1b61014dd786c704105e2851cea4280d5437ba38b40932"
    }
  },
  {
    "ts": null,
    "headline": "Reasons to Retain West Pharmaceutical Stock in Your Portfolio for Now",
    "summary": "WST leans on strong HVP demand, rising GLP-1 exposure and Annex 1 tailwinds, even as pricing and device margins weigh on near-term performance.",
    "url": "https://finnhub.io/api/news?id=1dfb5580fcf29646ef879a76dd5a88855a059163fea50cc1e813ab9026626b6f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765459920,
      "headline": "Reasons to Retain West Pharmaceutical Stock in Your Portfolio for Now",
      "id": 137758019,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "WST leans on strong HVP demand, rising GLP-1 exposure and Annex 1 tailwinds, even as pricing and device margins weigh on near-term performance.",
      "url": "https://finnhub.io/api/news?id=1dfb5580fcf29646ef879a76dd5a88855a059163fea50cc1e813ab9026626b6f"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific Sustains Momentum in the PFA Market: What's Next?",
    "summary": "BSX builds momentum in PFA as FARAPULSE posts strong growth, and new trial results and expanded FDA labeling boost its AF treatment push.",
    "url": "https://finnhub.io/api/news?id=39df9ccd5959cce2f16e69a88089cc42aacf81a2d072acb347103ebb471cada0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765458300,
      "headline": "Boston Scientific Sustains Momentum in the PFA Market: What's Next?",
      "id": 137757970,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "BSX builds momentum in PFA as FARAPULSE posts strong growth, and new trial results and expanded FDA labeling boost its AF treatment push.",
      "url": "https://finnhub.io/api/news?id=39df9ccd5959cce2f16e69a88089cc42aacf81a2d072acb347103ebb471cada0"
    }
  },
  {
    "ts": null,
    "headline": "BEAT Secures FDA Nod for First Cable-Free At-Home 12-Lead ECG System",
    "summary": "HeartBeam's FDA clearance for its cable-free at-home 12-lead ECG marks a pivotal step toward commercialization and broader cardiac-care adoption.",
    "url": "https://finnhub.io/api/news?id=5257d77795a1be25b6a2ebb58f362b05596098e2f5540162df16716e3d4171ed",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765455420,
      "headline": "BEAT Secures FDA Nod for First Cable-Free At-Home 12-Lead ECG System",
      "id": 137758021,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "HeartBeam's FDA clearance for its cable-free at-home 12-lead ECG marks a pivotal step toward commercialization and broader cardiac-care adoption.",
      "url": "https://finnhub.io/api/news?id=5257d77795a1be25b6a2ebb58f362b05596098e2f5540162df16716e3d4171ed"
    }
  },
  {
    "ts": null,
    "headline": "Reasons to Hold Fresenius Medical Stock in Your Portfolio for Now",
    "summary": "FMS's acquisitions, partnerships and global reach fuel growth, even as rising costs and optimization efforts weigh on near-term performance.",
    "url": "https://finnhub.io/api/news?id=fa10b3a0a3a95f799cb32454a38707e63d3b487b2d5cbb3d7e39d54069b36ae4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765455120,
      "headline": "Reasons to Hold Fresenius Medical Stock in Your Portfolio for Now",
      "id": 137758022,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "FMS's acquisitions, partnerships and global reach fuel growth, even as rising costs and optimization efforts weigh on near-term performance.",
      "url": "https://finnhub.io/api/news?id=fa10b3a0a3a95f799cb32454a38707e63d3b487b2d5cbb3d7e39d54069b36ae4"
    }
  }
]